Clinical efficacy of parathyroid autotransplantation into the forearm muscle in thyroid surgery: a retrospective cohort study on functional restoration Authors: Lifen Bai, Huiyin Zhu, Ling Zhou, Sheng Liu Published: 2026 ABSTRACT PurposeThis study was conducted to evaluate the clinical efficacy of autologous parathyroid transplantation into the forearm brachioradialis muscle during thyroid surgery and analyze the timing of graft function recovery.MethodsA total of 52 patients undergoing thyroid surgery with autologous parathyroid transplantation were selected. Serum parathyroid hormone (PTH) levels were measured at various postoperative intervals, and instances of hypoparathyroidism were recorded.ResultsPostoperative PTH levels on the transplant side were significantly higher than on the non-transplant side from week 1 to 1 year. Effective graft rates were 1.9% on day 1, 40.4% at week 1, 84.6% at 1 month, and stabilized at around 73% after 1 year. Transient hypoparathyroidism was observed in 17.3% of patients, with no permanent cases.ConclusionAutologous parathyroid transplantation into the forearm brachioradialis muscle effectively preserves parathyroid function, with grafts regaining optimal function within 2–3 months and the graft still having good secretory function 1 year after surgery. INTRODUCTION Hypoparathyroidism is a common complication of thyroid surgery, often resulting in significant morbidity due to the critical role of parathyroid glands in calcium homeostasis. Traditional management methods include oral calcium and vitamin D supplementation, but these approaches can be burdensome and not always effective [1]. Autologous parathyroid transplantation has emerged as a promising technique to preserve parathyroid function during thyroidectomy. Conventionally, parathyroid tissue is transplanted into the sternocleidomastoid muscle, but this method presents limitations such as difficulty in assessing graft function and potential complications from the secondary surgical site [2]. Recent studies have explored the transplantation of parathyroid tissue into the forearm brachioradialis muscle as an alternative. This method allows for easier monitoring of graft function through serum parathyroid hormone (PTH) levels in the transplanted limb and minimizes the risk of complications associated with cervical sites [34]. Therefore, forearm brachioradialis transplantation has shown superior characteristics in terms of reducing surgical trauma and convenience of prognosis monitoring. The purpose of this study is to evaluate the clinical efficacy of autologous parathyroid transplantation into the forearm brachioradialis muscle during thyroid surgery and to analyze the timing of graft function recovery. We hypothesize that this method will provide superior outcomes compared to traditional transplantation sites by offering more reliable graft function and fewer complications. Our research questions include: What is the optimal timing for graft function recovery? How do the serum PTH levels compare between the transplant and non-transplant sides over time? METHODS Participants and setting A total of 52 patients who underwent thyroid surgery at the Department of Thyroid and Breast Surgery, Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine, between January 2023 and June 2024, were selected. The inclusion criteria were: (1) the first thyroid surgery completed at our hospital, (2) normal preoperative PTH and blood calcium levels, (3) total thyroidectomy or lobectomy with or without central lymph node dissection, (4) intraoperative autologous transplantation of the parathyroid gland to the brachioradialis muscle. Exclusion criteria included severe liver and kidney dysfunction, incomplete clinical data, and ectopic parathyroid tissue found postoperatively. Informed consent was obtained from all patients, and the study was approved by the Ethics Committee of Shanghai Fourth People’s Hospital, School of Medicine, Tongji University (No. 2022-044-001). Surgical procedure Four experienced surgeons performed the surgeries. When the parathyroid gland was free or had a compromised blood supply, it was placed in a beaker with 0.9% sodium chloride solution. The plunger of a 5-mL syringe (without a needle) was pulled out, and the nipple interface of the syringe was blocked with a finger. The parathyroid gland, with a small amount of normal saline poured into the syringe barrel, was then cut into fragments (approximately 0.5 mm) with ophthalmic scissors to make approximately 2–3 mL of parathyroid suspension. The plunger was pushed back for later use. The PTH test strip was placed flat on a clean surface, and 2 drops of the tissue suspension were added to the sampling hole. After waiting for 15 minutes, once a positive result was confirmed (showing 2 fluorescent lines), the tissue suspension was injected into the brachioradialis muscle of the non-dominant forearm (1–1.5 cm away from the lateral side of the forearm and approximately 5 cm from the elbow) using the needle of a 20-mL syringe. During injection, the skin was pinched with the index finger and thumb, and the needle was inserted vertically to a depth of about 1.5 cm to ensure the needle tip entered the muscle (Fig. 1). Measurement of serum parathyroid hormone and calcium levels Serum PTH levels (reference range, 12–80 pg/mL) and serum calcium levels (2.11–2.52 mmol/L) were measured preoperatively and postoperatively on days 1, 3, and at 1 week, 1 month, 2 months, 3 months, 6 months, and 1 year. Hypocalcemia was defined as serum calcium of <2.11 mmol/L within 24 hours after surgery, requiring calcium/vitamin D replacement therapy at the time of hospital discharge [5]. Hypoparathyroidism was defined as PTH <12 pg/mL in both limbs. We defined permanent hypoparathyroidism as low PTH concentrations at 6 months postoperatively according to the European Society of Endocrinology [6] and the American Thyroid Association [7]. Data analysis Statistical analyses were conducted using IBM SPSS Statistics ver. 22.0 (IBM Corp.). Quantitative data were represented as mean ± standard deviation, with an independent samples t-test for intergroup comparisons. Categorical data were expressed as rates (%), with a two-sided significance level set at α = 0.05. RESULTS General information This study enrolled a total of 57 patients, 5 of whom were excluded due to postoperative loss to follow-up, and ultimately included 52 patients comprising 12 male and 40 female patients. The ages ranged from 26 to 78 years, with an average age of 51 years. A total of 53 parathyroid glands were transplanted, all performed as primary autologous transplantation, with 1 patient receiving 2 parathyroid glands. Patient characteristics, surgery, and pathologic diagnosis of patients undergoing autologous transplantation of parathyroid glands into the forearm brachioradialis muscle are summarized in Table 1. Postoperative complications Within 24 hours after surgery, 5 of 11 cases (45.4%) of bilateral thyroid cancer patients experienced transient hypocalcemia manifested as numbness in the limbs or around the mouth without significant muscle spasms or generalized convulsions. Postoperatively, 17.3% of patients developed transient hypoparathyroidism, and no cases of permanent hypoparathyroidism were identified. Additionally, 2 patients experienced neck surgical area bleeding that required reoperation; no bleeding or hematoma was noted at the transplant site (Table 2). Comparison of parathyroid hormone concentrations in the elbow head vein between the transplant side and non-transplant side The average preoperative PTH concentration in the patients’ systemic circulation was 31.81 pg/mL, and the average blood calcium concentration was 2.34 mmol/L, both within the normal range. On the first postoperative day, the PTH levels on both the graft and non-graft sides decreased with no significant difference between the 2 sides (P > 0.05). Statistical significance was observed in comparing the levels on both sides between postoperative week 1 and day 3, month 1 and week 1, and month 2 and month 1 (P < 0.05). There was a significant difference between the graft side at 6 months vs. 3 months and 1 year vs. 6 months (P < 0.05). No significant differences were observed on both sides when comparing 3 months vs. 2 months, the non-graft side’s 6 months vs. 3 months, and 1 year vs. 6 months (P > 0.05). The PTH levels on the graft side were statistically significantly higher than those on the non-graft side from week 1 to 1 year (P < 0.05) (Table 3). Within 1 week after surgery, the concentrations of PTH on both the graft side and the non-graft side showed a downward trend. One month after surgery, the PTH level on the graft side significantly increased, reaching a peak concentration 2–3 months later, which was higher than the normal range. Subsequently, it slowly decreased and stabilized but still remained above the presurgery PTH level (Fig. 2). We set a ratio of PTH between the graft side and non-graft side ≥1.5 as a criterion for effective transplantation. We found that the efficacy rate of autologous transplantation on postoperative days 1 and 3 was only 1.9% and 7.7%, respectively. One week after the transplantation, the efficacy rate was 40.4%. The efficacy rates at 1, 2, 3, and 6 months were 84.6%, 84.6%, 73.1%, and 69.2%, respectively. One year after surgery, 73.1% still displayed good graft function and PTH production. DISCUSSION Currently, the effectiveness of grafts is mainly assessed in clinical practice by measuring postoperative serum PTH concentrations, blood calcium levels, and clinical symptoms of patients. In previous studies, the sternocleidomastoid muscle was the preferred site for parathyroid transplantation in open surgery, which avoids a secondary surgical incision [8910]. However, this method cannot determine the function of the graft unless all of the parathyroid glands are removed for transplantation. In rare cases, if the graft needs to be removed, then reoperative surgery requires repeat cervical exploration, which may affect the patient’s prognosis, and transplantation in other muscle groups in the neck or trunk muscles will also face the same problems [48]. Forearm muscle or subcutaneous transplantation has been shown to be completely safe and reliable, and the difference in PTH concentration gradient between the transplanted and non-transplanted sides can be used as direct evidence of transplant success, and the graft can be easily removed [411]. In this study, we adopted the homogenate injection method to transplant the parathyroid gland into the brachioradialis muscle of the forearm. From the first week to 1 year after surgery, the PTH levels on the transplant side were significantly higher than those on the non-transplant side, showing a statistically significant difference (P < 0.05), proving that autologous parathyroid transplantation contributes to the recovery of parathyroid function. Postoperatively, 17.3% of patients developed transient hypoparathyroidism; no cases of permanent hypoparathyroidism were identified, and no bleeding or hematoma was noted at the transplant site. This approach does not involve surgical incision or muscle tissue dissection, and is simple, easy to implement, and effective. Within 1 week after surgery, the concentrations of PTH on both the graft side and the non-graft side showed a downward trend, likely due to ischemia of the grafts [12]. The transplanted parathyroid glands restored normal secretory function by the 4th week after surgery. The possible molecular mechanisms of parathyroid function recovery after transplantation include the upregulation of vascular endothelial growth factor, promotion of angiogenesis, and reestablishment of blood supply in the transplanted tissue. Studies have shown that these molecular mechanisms begin to act within 10 to 20 days after surgery, reaching a peak of functional recovery by the fourth week [1213]. Further research on these molecular mechanisms will help optimize transplantation methods and improve success rates. Two months after surgery, systemic (non-graft side) PTH returned to preoperative levels. After 2 to 3 months, PTH levels on the graft side peaked and remained above the normal range, reflecting optimal secretion status of the graft. After 6 months, PTH concentrations gradually declined and stabilized, possibly due to the normal functioning of the parathyroid glands retained in situ, which exerted negative feedback suppression on the grafts. Furthermore, by this time, the body had transitioned from a compensatory state of postoperative parathyroid glands to a normal physiological process, wherein both the parathyroid glands retained in situ and the transplanted glands could secrete normal PTH according to the body’s needs [14]. A PTH concentration ratio of the cubital fossa vein in both arms reaching 1.5 times has been widely recognized as strong evidence for the recovery of parathyroid function after transplantation [3415]. Cavallaro et al. [4] found that the graft response rate was 79% at 1 month postoperatively, 92.8% at 3 and 6 months, and 90.5% of patients still had good graft function at 1 year after surgery. Li et al. [3] found that the effective rates of grafts at 1 month, 2 months, 6 months, 1 year, and 3 years after surgery were 73.5%, 75.2%, 72.3%, 71%, and 72.7%, respectively. In our study, the efficacy rates at 1 week, 1 month, 2 months, 3 months, and 6 months were 40.4%, 84.6%, 84.6%, 73.1%, and 69.2%, respectively. One year after surgery, 73.1% still displayed good graft function and PTH production. Because the secretion of PTH is regulated by various factors, such as blood calcium, the surviving parathyroid glands do not secrete a sufficiently large amount of PTH to reach a constant ratio of >1.5. Furthermore, the negative feedback effect of recovery of systemic PTH on grafts may also lead to a decrease in this ratio. There were several limitations to this study. First, this was a single-center, small-sample study, lacking a randomized control group; a future study with a larger cohort size is needed to further validate the effectiveness of this transplant method. Second, this study can only conclude that the graft still has good secretory function 1 year after surgery, and whether the graft can survive longer needs to be further tracked. Furthermore, the operator’s judgment of parathyroid function was subjective to an extent; development of technology that can objectively evaluate parathyroid blood supply is warranted. In conclusion, this study demonstrates that autologous transplantation of the parathyroid gland into the brachioradialis muscle is a safe and effective method that aids in the recovery of parathyroid function, and the implantation in the brachioradialis muscle allows for good assessment of graft function. We also found that the graft restores secretory function 1 month after operation, reaches optimal secretory status within 2–3 months, and the graft still has good secretory function 1 year after surgery.